Bishop JF - Search Results

1

The roles of patient and observer assessments in anti-emetic trials.

Olver IN, Matthews JP, Bishop JF, Smith RA. Olver IN, et al. Among authors: bishop jf. Eur J Cancer. 1994;30A(9):1223-7. doi: 10.1016/0959-8049(94)90162-7. Eur J Cancer. 1994. PMID: 7999403 Clinical Trial.

2

A randomised double blind crossover study of domperidone and prochlorperazine suppositories for controlling emesis in outpatients receiving chemotherapy.

Olver IN, Laidlaw CR, Matthews JP, Bishop JF, Hayes AM, Wolf M, Toner GC. Olver IN, et al. Among authors: bishop jf. Eur J Cancer. 1994;30A(4):426-9. doi: 10.1016/0959-8049(94)90411-1. Eur J Cancer. 1994. PMID: 8018396 Clinical Trial.

3

A randomised trial of dexamethasone, lorazepam and prochlorperazine for emesis in patients receiving chemotherapy.

Bishop JF, Matthews JP, Wolf MM, Oliver IN, Reynolds S, Walpole E, Rischin D, Buchanan L, Tan LG. Bishop JF, et al. Eur J Cancer. 1992;28(1):47-50. doi: 10.1016/0959-8049(92)90382-c. Eur J Cancer. 1992. PMID: 1567690 Clinical Trial.

4

A randomised double-blind study of high-dose intravenous prochlorperazine versus high-dose metoclopramide as antiemetics for cancer chemotherapy.

Olver IN, Wolf M, Laidlaw C, Bishop JF, Cooper IA, Matthews J, Smith R, Buchanan L. Olver IN, et al. Among authors: bishop jf. Eur J Cancer. 1992;28A(11):1798-802. doi: 10.1016/0959-8049(92)90006-n. Eur J Cancer. 1992. PMID: 1389512 Clinical Trial.

5

Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine.

Bishop JF, Olver IN, Wolf MM, Matthews JP, Long M, Bingham J, Hillcoat BL, Cooper IA. Bishop JF, et al. J Clin Oncol. 1984 Jun;2(6):691-5. doi: 10.1200/JCO.1984.2.6.691. J Clin Oncol. 1984. PMID: 6374058 Clinical Trial.

6

A phase I and pharmacokinetics study of prolonged ambulatory-infusion carboplatin.

Olver IN, Webster LK, Millward MJ, Stokes KH, Bishop JF. Olver IN, et al. Among authors: bishop jf. Cancer Chemother Pharmacol. 1995;37(1-2):79-85. doi: 10.1007/BF00685632. Cancer Chemother Pharmacol. 1995. PMID: 7497601 Clinical Trial.

7

The effect of danazol on tumour control and weight loss in patients on tamoxifen therapy for advanced breast cancer: a randomised double-blind placebo controlled trial.

Bishop JF, Smith JG, Jeal PN, Murray R, Drummond RM, Pitt P, Olver IN, Bhowal AK. Bishop JF, et al. Eur J Cancer. 1993;29A(6):814-8. doi: 10.1016/s0959-8049(05)80415-0. Eur J Cancer. 1993. PMID: 8484970 Clinical Trial.

8

Concurrent radiotherapy and continuous ambulatory infusion 5-fluorouracil in advanced head and neck cancer.

Olver IN, Hughes PG, Smith JG, Narayan K, Bishop JF. Olver IN, et al. Among authors: bishop jf. Eur J Cancer. 1996 Feb;32A(2):249-54. doi: 10.1016/0959-8049(95)00539-0. Eur J Cancer. 1996. PMID: 8664036 Clinical Trial.

9

A phase II trial of cisplatin and interferon alpha 2b in patients with advanced bladder cancer.

Parnis FX, Olver IN, Sandeman T, Bishop JF, Laidlaw C. Parnis FX, et al. Among authors: bishop jf. Am J Clin Oncol. 1997 Jun;20(3):319-21. doi: 10.1097/00000421-199706000-00024. Am J Clin Oncol. 1997. PMID: 9167763 Clinical Trial.

10

Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparison.

Toner GC, Shapiro JD, Laidlaw CR, Rischin D, Millward MJ, Wolf M, Januszewicz H, Mitchell SV, Curran AC, Matthews JP, Bishop JF. Toner GC, et al. Among authors: bishop jf. J Clin Oncol. 1998 Dec;16(12):3874-9. doi: 10.1200/JCO.1998.16.12.3874. J Clin Oncol. 1998. PMID: 9850033 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters